James DArecca insider trades

Open-market stock purchases and sales by James DArecca, Director at Prestige Consumer HealthCare Inc, from SEC Form 4 filings since May 9, 2014.

Recent trades

DateStockTradeValue
Aug 4, 2026PBH Prestige Consumer HealthCare IncBought (not open market)—
May 15, 2026HAE Haemonetics CorpSold (not open market)$141K
May 15, 2026HAE Haemonetics CorpBought (not open market)—
May 1, 2026HAE Haemonetics CorpSold (not open market)$38.8K

Companies traded

  • PBH Prestige Consumer HealthCare Inc: other filings, last Aug 4, 2026
  • HAE Haemonetics Corp: other filings, last May 15, 2026
  • TXMD TherapeuticsMD, Inc: 1 sale, last Aug 12, 2021
  • AGN Allergan plc: other filings, last May 8, 2020
  • ACT Actavis plc: other filings, last Mar 5, 2015

Get free alerts when James DArecca files a new trade →